Hongyang Wang

Active 1997–2026

328
Papers
31,762
Citations
99
h-index
264
i10-index

Citations

Citations per year for Hongyang Wang1991: 1 citations1992: 1 citations1995: 1 citations1997: 7 citations1998: 29 citations1999: 35 citations2000: 32 citations2001: 22 citations2002: 15 citations2003: 16 citations2004: 12 citations2005: 15 citations2006: 25 citations2007: 26 citations2008: 27 citations2009: 37 citations2010: 53 citations2011: 92 citations2012: 121 citations2013: 178 citations2014: 170 citations2015: 209 citations2016: 210 citations2017: 305 citations2018: 349 citations2019: 1,219 citations2020: 1,713 citations2021: 1,946 citations2022: 1,723 citations2023: 1,346 citations2024: 2,018 citations2025: 1,231 citations2026: 68 citations1993–1994: no citations, so these years are not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 6,882 citing papers, 41.8% of this breakdownUnited States: 2,663 citing papers, 16.2% of this breakdownGermany: 518 citing papers, 3.1% of this breakdownUnited Kingdom: 506 citing papers, 3.1% of this breakdownItaly: 496 citing papers, 3% of this breakdownJapan: 359 citing papers, 2.2% of this breakdownIndia: 336 citing papers, 2% of this breakdownSouth Korea: 293 citing papers, 1.8% of this breakdownFrance: 274 citing papers, 1.7% of this breakdownHong Kong: 269 citing papers, 1.6% of this breakdownSpain: 256 citing papers, 1.5% of this breakdownAustralia: 253 citing papers, 1.5% of this breakdown
0%41.8%Other 20.5%

Fields

  • Biochemistry, Genetics and Molecular Biology47.9%
  • Medicine34.1%
  • Immunology and Microbiology6.4%
  • Engineering3.4%
  • Neuroscience2.4%
  • Computer Science1.9%
  • Other3.9%

Topics

  • MicroRNA in disease regulation4.3%
  • Cancer-related molecular mechanisms research4%
  • Circular RNAs in diseases2.9%
  • Extracellular vesicles in disease2.8%
  • RNA modifications and cancer2.6%
  • Hepatocellular Carcinoma Treatment and Prognosis2.3%
  • Other81.1%

Coauthors

All papers

Open in search
  1. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Lin, Jun Lin, Yun Ling, Jianwei Liu, Jianwei Liu, Nianping Liu, Shu-Qiang Liu, Meng Luo, Qiang Ma, Qibing Song, Wujianan Sun, Feng Wang, Feng Wang, Feng Wang, Ying Wang, Xiaofeng Wen, Qian Wu, Gang Xu, Xudong Xing, Xinxin Xiong, Xudong Xing, Dongdong Yu, Chonghai Yin, Dongdong Yu, Kezhuo Yu, Jin Yuan, Biao Zhang, Peipei Zhang, Tong Zhang, Jincun Zhao, Peidong Zhao, Peidong Zhao, Jianfeng Zhou, Wei Zhou, Sujuan Zhong, Xiaosong Zhong, Shuye Zhang, Jiahua Zou, Ping Zhu, Bin Zou, Jiahua Zou, Zengtao Zuo, Fan Bai, Xi Huang, Penghui Zhou, Qinghua Jiang, Zhiwei Huang, Jin‐Xin Bei, Lai Wei, Xiu‐Wu Bian, Xindong Liu, Tao Cheng, Xiangpan Li, Pingsen Zhao, Pingsen Zhao, Fu‐Sheng Wang, Xiaoqun Wang, Hongyang Wang, Bing Su, Bing Su, Zheng Zhang, Kun Qu, Xiaoqun Wang, Jiekai Chen, Ronghua Jin, Zemin Zhang - Cell 2021 cited by 947

  2. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 1,051

  3. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis

    Authors: , , , , , , , , , , , , , , , , , - Nature 2020 cited by 360

  4. Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2016 cited by 1,174

  5. Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

    Authors: , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 366

  6. NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion

    Authors: , , , , , , , , , , , , - Cell Metabolism 2020 cited by 302

  7. M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , - Cancer Research 2021 cited by 256

  8. Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation

    Authors: , , , , , , , , , , , , - Science Advances 2023 cited by 139

  9. New knowledge of the mechanisms of sorafenib resistance in liver cancer

    Authors: , , , - Acta Pharmacologica Sinica 2017 cited by 727

  10. High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice

    Authors: , , , , , , , , , , , , , , , - Gastroenterology 2020 cited by 217

  11. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2017 cited by 541

  12. Single‐Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids

    Authors: , , , , , , , , , , , , , , , - Advanced Science 2021 cited by 133

  13. Deep whole-genome analysis of 494 hepatocellular carcinomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hongyang Wang - Nature 2024 cited by 128

  14. Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , - Cell Discovery 2023 cited by 107

  15. A human circulating immune cell landscape in aging and COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , - Protein & Cell 2020 cited by 284

  16. Integrated Multi-Omics Landscape of Liver Metastases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hongyang Wang, Peng Wang, Lei Chen - Gastroenterology 2022 cited by 106

  17. Extracellular signals regulate the biogenesis of extracellular vesicles

    Authors: , , , , , - Biological Research 2022 cited by 105

  18. Single tumor-initiating cells evade immune clearance by recruiting type II macrophages

    Authors: , , , , , , , , , , , , , , , , - Genes & Development 2017 cited by 294

  19. A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , - Hepatology 2017 cited by 380

  20. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wan Yee Lau, Chuan He, Hongyang Wang, Wei Zhang, Jia Fan - Gut 2019 cited by 293

  21. Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis

    Authors: , , , , , , , , , , , , , , - Arthritis & Rheumatology 2017 cited by 201

  22. TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer

    Authors: , , , , , , , , , , , , , , - Nature Communications 2024 cited by 96

  23. Heterogeneity of liver cancer and personalized therapy

    Authors: , - Cancer Letters 2015 cited by 348

  24. Conductive Nerve Guidance Conduits Based on Morpho Butterfly Wings for Peripheral Nerve Repair

    Authors: , , , , , , , , , , , - ACS Nano 2022 cited by 113